Carlos Trujillo
CIK 1464520 · Chief Financial Officer · last filed 2023-11-22
Carlos Trujillo is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for PMCB, was dated Nov 22, 2023. 2 SEC filings were submitted jointly with PharmaCyte Biotech, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
27
$0
Filer Profile
IRVINE, CA 92618
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMCB | Chief Financial Officer | — | $0.44 | — | $0 | 1 | 2023-11-22 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-22 | PMCB | Grant (A) | — | $0 | EDGAR |
| 2013-04-08 | — | Other (J) | −220,606 | -$221 | |
| 2012-12-28 | — | Sell (S) | −145,795 | -$11.4K | |
| 2012-11-27 | — | Grant (A) | +4,392,411 | $134.0K | |
| 2012-10-09 | — | Sell (S) | −40,100 | -$1.2K | |
| 2012-09-28 | — | Sell (S) | −75,595 | -$2.5K | |
| 2012-09-10 | — | Sell (S) | −124,800 | -$5.8K | |
| 2012-09-04 | — | Mixed | +353,295 | $30.3K | |
| 2012-08-10 | — | Sell (S) | −12,028 | -$3.0K | |
| 2012-07-23 | — | Other (J) | +22,060,607 | $22.1K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.